Neonatal Toxicology Market Size, Share, Trends, Industry Analysis Report By Specimen (Urine, Umbilical Cord, Meconium, And Others), By Technology, By Drug, By End Use, and By Region – Market Forecast, 2025–2034

The neonatal toxicology market size is expected to reach USD 22.22 Billion by 2034, according to a new study by Polaris Market Research. The report “Neonatal Toxicology Market Size, Share, Trends, Industry Analysis Report By Specimen (Urine, Umbilical Cord, Meconium, And Others), By Technology, By Drug, By End Use, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neonatal toxicology market provides solutions for early detection, monitoring, and management of drug exposure and toxic substances in newborns, covering hospitals, diagnostic laboratories, and research institutions. Market growth is driven by increasing awareness of neonatal health, rising incidence of neonatal disorders, and the need for early intervention.

In addition, growing investments in advanced diagnostic services and technologies and adoption of non-invasive testing methods are accelerating the use of accurate, rapid, and reliable neonatal toxicology solutions globally.

Neonatal Toxicology Market Report Highlights

Based on Specimen, the meconium segment dominated in 2024, owing to its ability to provide a longer detection window for prenatal drug exposure.

In terms of Technology, the immunoassay segment held the largest share, due to its wide clinical adoption, faster processing, and cost-effectiveness for routine neonatal screening.

Based on Drug, the opioids segment led the market, driven by rising incidence of neonatal opioid withdrawal syndrome (NOWS) in several countries.

In terms of End Use, hospitals dominated, as they serve as the primary centers for immediate neonatal screening and early intervention.

North America led the market in 2024, fueled by high prevalence of neonatal exposure to drugs, including opioids and prescription medications.

Asia Pacific is expected to witness strong growth, supported by increasing awareness among healthcare professionals and parents regarding neonatal health and early intervention.

Key players in the global market include Agilent Technologies, Inc., ARUP Laboratories, Inc., Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Inc., Eurofins Scientific SE, Labcorp Holdings, Inc., Medpace Holdings, Inc., Omega Laboratories, Inc., QuidelOrtho Corporation, Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., United States Drug Testing Laboratories, Inc. (USDTL), and WuXi AppTec Co., Ltd.

Request a free sample copy or read the full market insights : neonatal toxicology market report

Polaris Market Research has segmented the market report based on specimen, technology, drug, end use, and region:

By Specimen Outlook (Revenue, USD Billion, 2020–2034)

Urine

Umbilical Cord

Meconium

Others

By Technology Outlook (Revenue, USD Billion, 2020–2034)

Mass spectroscopy

Immunoassay

By Drug Outlook (Revenue, USD Billion, 2020–2034)

Cannabinoids

Opioids

Cocaine

Benzodiazepines

Amphetamines

Other illicit drugs

By End Use Outlook (Revenue, USD Billion, 2020–2034)

Hospitals

Clinical Laboratories

Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America Show more